The consensus among analysts is that Vir Biotechnology, Inc. (VIR) is a Hold stock at the moment, with a recommendation rating of 3.2. 1 analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 5 have rated it as a Hold, with 2 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.62.
Vir Biotechnology, Inc. (NASDAQ:VIR) trade information
Despite being -6.46% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the VIR stock price touched $50.75- or saw a rise of 28.43%. Year-to-date, Vir Biotechnology, Inc. shares have moved 188.83%, while the 5-day performance has seen it change -6.61%. Over the past 30 days, the shares of Vir Biotechnology, Inc. (NASDAQ:VIR) have changed 6.26%. Short interest in the company has seen 2.79 Million shares shorted with days to cover at 1.75.
Vir Biotechnology, Inc. (VIR) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -443.3% while over the next 5 years, the company’s earnings are expected to increase by 0%.
Vir Biotechnology, Inc. (NASDAQ:VIR)’s Major holders
Insiders own 14.54% of the company shares, while shares held by institutions stand at 63.78% with a share float percentage of 74.63%. Investors are also buoyed by the number of investors in a company, with Vir Biotechnology, Inc. having a total of 83 institutions that hold shares in the company. The top two institutional holders are SB Investment Advisers (UK) LTD with over 22.62 Million shares worth more than $775.07 Million. As of March 30, 2020, SB Investment Advisers (UK) LTD held 19.18% of shares outstanding.
The other major institutional holder is Temasek Holdings (Private) Limited, with the holding of over 5.5 Million shares as of March 30, 2020. The firm’s total holdings are worth over $188.48 Million and represent 4.66% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Smallcap World Fund and iShares Russell 2000 ETF. As of December 30, 2019, the former fund manager holds about 0.83% shares in the company for having 983300 shares of worth $12.36 Million while later fund manager owns 164.61 Thousand shares of worth $5.64 Million as of March 30, 2020, which makes it owner of about 0.14% of company’s outstanding stock.